Glenmark Pharmaceuticals (Australia) Pty. Limited, is part of Glenmark Pharmaceuticals Limited, a research‐led, global pharmaceutical company, having a presence across innovative, generics, and over-the-counter (OTC) segments; with a focus on the therapeutic areas of respiratory, dermatology and oncology. The company has 14 world‐class manufacturing facilities across 4 continents, and operations in over 80 countries.

Glenmark Pharmaceuticals started operations in Australia in 2018 and since then, we have been keeping patients at the centre of everything we they do. At Glenmark, we are committed to providing high-quality affordable medicines for our Australian patients.

By leveraging the global strength of Glenmark Pharmaceuticals in dermatology and respiratory, Glenmark Australia aims to significantly improve the lives of Australian patients and their families.

“Australia is a key market for Glenmark. We have a really strong pipeline of medicines for various conditions. We are dedicated to enhancing the healthcare landscape in Australia by providing quality products that offer more choice for patients,” Michael Moffitt, Country Manager at Glenmark Australia and New Zealand.